Skip to main content

Patrys acquire Perth biotech for delirium drug

Just in

Bookmark

Save articles for future reference.

A world-first antipsychotic injectable drug developed in Perth will accelerate its path to market after the company behind it, Reliis, was acquired by a Melbourne biotechnology developer.

X

To read our articles you will need to either login or subscribe.